Market Place
Sourcing Support
Novavax-Sanofi Deal Hits $50M Milestone In Growth Strategy
14 Dec 2024 //
PR NEWSWIRE
Novavax sells Czech production plant to Novo Nordisk for $200M
04 Dec 2024 //
FIERCE PHARMA
Novavax Announces Inducement Awards under Nasdaq Rule 5635(c)(4)
15 Nov 2024 //
PR NEWSWIRE
Novavax to Participate in Jefferies London Healthcare Conference
13 Nov 2024 //
PR NEWSWIRE
Novavax Lowers 2024 Revenue Forecast on COVID Vaccine Decline
13 Nov 2024 //
REUTERS
Novavax Reports Q3 2024 Financial Results & Operational Highlights
12 Nov 2024 //
PR NEWSWIRE
US FDA lifts clinical hold on Novavax`s combo COVID-flu shot
11 Nov 2024 //
REUTERS
Novavax coughs up $123.8M to settle UK COVID vaccine dispute
07 Nov 2024 //
FIERCE PHARMA
Novavax, UK terminate vaccine supply agreement
06 Nov 2024 //
REUTERS
Novavax, UK terminate vaccine supply agreement
05 Nov 2024 //
REUTERS
Novavax to Host Q3 2024 Financial Results Call on Nov 12
04 Nov 2024 //
PR NEWSWIRE
FDA pause Novavax trial of combo COVID-flu shot on safety concerns
17 Oct 2024 //
REUTERS
Novavax`s COVID-19 Combination and Stand-alone Influenza Ph 3 Trial
16 Oct 2024 //
PR NEWSWIRE
Novavax Receives EU Authorization For Updated COVID Vaccine
09 Oct 2024 //
REUTERS
Novavax`s Updated COVID-19 Vaccine Receives Authorization In EU
09 Oct 2024 //
PR NEWSWIRE
Novavax COVID-19 Vaccine Expands Options, Approved For Use
30 Sep 2024 //
PRESS RELEASE
Novavax Names Dr. Draghia-Akli As New EVP And R&D Head
25 Sep 2024 //
PR NEWSWIRE
Novavax 2024-2025 COVID-19 Vaccine Authorized For Use In The US
31 Aug 2024 //
PR NEWSWIRE
Novavax cuts 2024 revenue forecast, shrinks European presence
08 Aug 2024 //
REUTERS
Novavax Explores Sale Of Czech Manufacturing Plant
08 Aug 2024 //
FIERCE PHARMA
Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights
08 Aug 2024 //
PR NEWSWIRE
Novavax To Host Q2 2024 Results Call On August 8
01 Aug 2024 //
PR NEWSWIRE
Zomedica Expand Truforma Addressable Market with Launch of Equine Cortisol Assay
27 Jun 2024 //
ACCESSWIRE
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
15 Jun 2024 //
REUTERS
Novavax Submits Updated COVID-19 Vaccine To US FDA
14 Jun 2024 //
PR NEWSWIRE
FDA recommends updated Covid-19 vaccines targeting JN.1
06 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
Novavax to Participate in 2024 Jefferies Global Healthcare Conference
30 May 2024 //
PR NEWSWIRE
SII ships first doses of Oxford, Novavax-partnered malaria shot
20 May 2024 //
FIERCE PHARMA
Shah Capital ends campaign against Novavax board after Sanofi deal
20 May 2024 //
REUTERS
Novavax`s license deal with Sanofi at lofty valuation sends shares soaring
11 May 2024 //
REUTERS
Novavax, Sanofi COVID-19 Vaccine, Flu-COVID Combo Deal
10 May 2024 //
PR NEWSWIRE
Novavax Q1 2024 Financials, Operational Highlights
10 May 2024 //
PR NEWSWIRE
Sanofi, Novavax COVID-19 Vaccine, Flu-COVID Combo Deal
10 May 2024 //
PRESS RELEASE
France`s Sanofi in COVID-19 vaccine deal with Novavax
09 May 2024 //
REUTERS
Novavax erases doubts about its ability to remain in business
09 May 2024 //
REUTERS
Novavax Q1 2024 Results Call On May 10
07 May 2024 //
PR NEWSWIRE
Shah Capital urges Novavax shareholders to vote against three directors
06 May 2024 //
REUTERS
Activist hedge fund seeks big shake-up at Novavax
15 Apr 2024 //
PHARMAPHORM
Novavax investor Shah Capital pushes for board shakeup
15 Apr 2024 //
REUTERS
Hedge fund Shah Capital recommends two new candidates for Novavax board
15 Apr 2024 //
REUTERS
Novavax Presents Data on Updated on its COVID-19-Influenza Combination Vaccine
01 Apr 2024 //
PR NEWSWIRE
Novavax to Participate in TD Cowen`s 44th Annual Health Care Conference
29 Feb 2024 //
PRESS RELEASE
Novavax’s COVID-19 Vaccine Available as Additional Dose for Individuals Aged 65
28 Feb 2024 //
PRESS RELEASE
After cuts, Novavax`s Q4 performance startles investors
28 Feb 2024 //
FIERCE PHARMA
Novavax settles dispute with international vaccine group Gavi
23 Feb 2024 //
REUTERS
Novavax to Host Conference to Discuss Q4 and Full Year 2023 Financial Results
20 Feb 2024 //
PR NEWSWIRE
R21/Matrix-M™ Malaria Vaccine Phase 3 Trial Results Published in The Lancet
02 Feb 2024 //
PRESS RELEASE
Novavax announces fresh round of layoffs to rein in costs
01 Feb 2024 //
REUTERS
Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
PR NEWSWIRE
Novavax`s COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan
18 Dec 2023 //
PR NEWSWIRE
Novavax`s Updated COVID-19 Vaccine Now Authorized in Canada
05 Dec 2023 //
PR NEWSWIRE
Novavax`s COVID-19 Vaccine Now an Option for All 194 Member States
28 Nov 2023 //
PR NEWSWIRE
WHO authorizes emergency use of Novavax`s updated COVID shot
28 Nov 2023 //
REUTERS
Novavax Makes Changes to Executive Leadership Team
17 Nov 2023 //
PR NEWSWIRE
Novavax to Participate in Jefferies London Healthcare Conference
10 Nov 2023 //
PR NEWSWIRE
Novavax plans for 2nd round of cuts, including more layoffs
09 Nov 2023 //
FIERCE BIOTECH
Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results
02 Nov 2023 //
PR NEWSWIRE
Novavax`s Updated Covid-19 Vaccine Now Approved In The EU
01 Nov 2023 //
REUTERS
Novavax`s Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion
31 Oct 2023 //
PR NEWSWIRE
Novavax Receives Full Marketing Authorization for Nuvaxovid in UK
18 Oct 2023 //
PR NEWSWIRE
